SARS-CoV-2 re-infection, vaccination and neutralizing antibodies

Detalles Bibliográficos
Autores principales: Bongiovanni, Marco, Spada, Elena, De Angelis, Cristina, Liuzzi, Gianmaria, Giuliani, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886678/
https://www.ncbi.nlm.nih.gov/pubmed/35245582
http://dx.doi.org/10.1016/j.jinf.2022.02.033
_version_ 1784660720176070656
author Bongiovanni, Marco
Spada, Elena
De Angelis, Cristina
Liuzzi, Gianmaria
Giuliani, Giuseppe
author_facet Bongiovanni, Marco
Spada, Elena
De Angelis, Cristina
Liuzzi, Gianmaria
Giuliani, Giuseppe
author_sort Bongiovanni, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-8886678
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88866782022-03-02 SARS-CoV-2 re-infection, vaccination and neutralizing antibodies Bongiovanni, Marco Spada, Elena De Angelis, Cristina Liuzzi, Gianmaria Giuliani, Giuseppe J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-06 2022-03-01 /pmc/articles/PMC8886678/ /pubmed/35245582 http://dx.doi.org/10.1016/j.jinf.2022.02.033 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Bongiovanni, Marco
Spada, Elena
De Angelis, Cristina
Liuzzi, Gianmaria
Giuliani, Giuseppe
SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
title SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
title_full SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
title_fullStr SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
title_full_unstemmed SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
title_short SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
title_sort sars-cov-2 re-infection, vaccination and neutralizing antibodies
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886678/
https://www.ncbi.nlm.nih.gov/pubmed/35245582
http://dx.doi.org/10.1016/j.jinf.2022.02.033
work_keys_str_mv AT bongiovannimarco sarscov2reinfectionvaccinationandneutralizingantibodies
AT spadaelena sarscov2reinfectionvaccinationandneutralizingantibodies
AT deangeliscristina sarscov2reinfectionvaccinationandneutralizingantibodies
AT liuzzigianmaria sarscov2reinfectionvaccinationandneutralizingantibodies
AT giulianigiuseppe sarscov2reinfectionvaccinationandneutralizingantibodies

Ejemplares similares